Caribou Biosciences (CRBU) Other Operating Expenses (2025)

Caribou Biosciences (CRBU) reported Other Operating Expenses of $12.1 million for Q2 2025.

Caribou Biosciences (CRBU) Other Operating Expenses (2025) Analysis & Trends

Caribou Biosciences (CRBU) has 1 years of Other Operating Expenses data on file, last reported at $12.1 million in Q2 2025.

  • Other Operating Expenses for Q2 2025 came in at $12.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (changed N/A YoY), and the FY2025 annual result was $12.1 million, changed N/A from the prior year.
  • Other Operating Expenses held at $12.1 million in Q2 2025 per CRBU's latest filing.
  • Over five years, Other Operating Expenses peaked at $12.1 million in Q2 2025 and troughed at $12.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Caribou Biosciences 156.73 Mn 39.11 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 12.15 Mn